Herbalife LTD Form 4 insider transactions
NYSE
Troy Hicks, Chief Operating Officer of Herbalife Ltd., reports the acquisition and disposal of company stock and stock appreciation rights.
NYSE
Form 4: Herbalife Executive Stephan Paulo Gratziani Reports Acquisition of Stock Appreciation Rights
Herbalife President Stephan Paulo Gratziani reports the acquisition of stock appreciation rights (SARs) in a recent SEC filing.
NYSE
Herbalife CEO Michael Johnson was granted stock appreciation rights (SARs) under the company's 2023 Stock Incentive Plan.
NYSE
John DeSimone, CFO of Herbalife Ltd., reported the disposal of 18,355 common stock shares to cover tax obligations related to vesting Restricted Stock Units.
NYSE
Stephan Paulo Gratziani, President of Herbalife, reports disposing of 4,150 common stock shares to cover tax obligations related to vesting Restricted Stock Units.
NYSE
Herbalife CEO Michael Johnson disposed of 125,600 shares of common stock on February 16, 2025, to cover tax obligations related to vesting restricted stock units.
NYSE
Herbalife CEO Michael Johnson disposed of 87,682 shares of common stock to cover tax obligations related to previously granted restricted stock units.
NYSE
Herbalife's Chief Legal Officer, Henry C. Wang, reports the withholding of shares to cover tax obligations and additional share purchases through the company's employee stock purchase plan.
NYSE
Herbalife director Juan Miguel Mendoza purchased 2,500 shares of common stock in the open market at an average price of $8.49.
NYSE
Director Juan Miguel Mendoza reports acquiring 5,000 shares of Herbalife Ltd. (HLF) in two transactions on November 4th and 5th, 2024.
NYSE
Stephan Paulo Gratziani, President at Herbalife, disposed of 3,463 shares to cover tax obligations related to vesting restricted stock units.
NYSE
Director Juan Miguel Mendoza recently acquired 10,000 shares of Herbalife Ltd. at an average price of $7.11, increasing his total holdings to 120,000 shares.
NYSE
Director Juan Miguel Mendoza increased his holdings in Herbalife Ltd. by purchasing 10,000 shares of common stock at $8.72 per share on August 26, 2024.
NYSE
Director Juan Miguel Mendoza increased his stake in Herbalife by purchasing 6,721 shares at an average price of $8.01.
NYSE
Director Perkins Miller reports acquisition of 11,870 restricted stock units in Herbalife Ltd.
NYSE
Director Juan Miguel Mendoza reports acquiring additional Herbalife shares through open market purchases, increasing his total holdings.
NYSE
Director Juan Miguel Mendoza increased his holdings in Herbalife Ltd. by purchasing shares on May 6th and 7th, 2024.
NYSE
Director Sophie L'Helias reports acquisition of 15,657 restricted stock units in Herbalife Ltd.
NYSE
EVP and General Counsel of Herbalife, Henry C. Wang, reports acquisition of restricted stock units and stock appreciation rights, along with tax-related disposals.
NYSE
Director Maria Otero reports the acquisition of 15,657 restricted stock units in Herbalife Ltd.
NYSE
Director Juan Miguel Mendoza reports acquisition of 15,657 restricted stock units in Herbalife Ltd.
NYSE
Director Rodica Macadrai reports acquisition of 15,657 Herbalife shares through restricted stock units.
NYSE
Director Michael J. Levitt reported acquiring 15,657 shares of Herbalife Ltd. common stock on May 3, 2024, through restricted stock units.
NYSE
Director Alan W. LeFevre reports acquiring 18,266 shares of Herbalife Ltd. common stock through restricted stock units.
NYSE
EVP & Chief of Staff Ibelis Montesino reports acquisition of restricted stock units and stock appreciation rights, as well as disposition of shares to cover tax obligations.
NYSE
Frank Lamberti, Herbalife's Chief Operating Officer, reports acquisition and disposal of Herbalife stock and stock appreciation rights.
NYSE
Jehangir D. Irani, SVP, PAO of Herbalife Ltd., reports acquisition of restricted stock units and disposition of shares to cover tax obligations.
NYSE
Stephan Paulo Gratziani, President at Herbalife, reports acquisition of restricted stock units and stock appreciation rights.
NYSE
Director Celine Del Genes reports acquisition of 15,657 restricted stock units in Herbalife Ltd.
NYSE
Director Richard H. Carmona reports acquiring 15,657 shares of Herbalife common stock through restricted stock units.